KEGG: mmu:386611
UniGene: Mm.436547
RNF133 is a testis-specific E3 ubiquitin ligase that plays a critical role in male fertility and spermiogenesis. It functions as part of the endoplasmic reticulum (ER) quality control system that recognizes and degrades proteins through the ubiquitin-proteasome pathway. Knockout studies have demonstrated that RNF133 is essential for normal sperm morphology, motility, and function, with male mice lacking RNF133 displaying severe subfertility .
RNF133 contains one transmembrane region and one RING finger domain positioned after the transmembrane region, with this domain localized in the cytoplasm. In silico protein structure prediction confirms these domains, and immunostaining studies have shown that recombinantly expressed human RNF133 localizes to the endoplasmic reticulum (ER) . This structural arrangement is consistent with its proposed function in ER-associated degradation (ERAD) .
RT-PCR analysis of mouse testes at different postnatal days reveals that RNF133 expression begins around postnatal day 25, which corresponds to the period when round spermatids are transitioning to elongating spermatids. This specific temporal expression pattern suggests that RNF133 functions primarily during the later stages of spermiogenesis, particularly in sperm maturation and cytoplasmic remodeling processes .
CRISPR/Cas9-mediated gene knockout in mice has proven to be an effective approach for studying RNF133 function. The generation of specific single-guide RNAs (sgRNAs) targeting the RNF133 gene, followed by phenotypic analysis of the resulting knockout mice, provides valuable insights into the physiological role of this protein. Recommended assessments include:
Fertility testing through timed matings
In vitro and in vivo fertilization assays
Analysis of sperm parameters (count, morphology, motility)
Ultrastructural examination of sperm using electron microscopy
Comparative analysis between RNF133 heterozygous and knockout mice has revealed significant differences in pregnancy success rates and number of pups per plug, demonstrating the crucial role of RNF133 in male fertility .
When investigating RNF133 function, researchers should implement the following control strategy:
Use heterozygous (HET) littermates as primary controls rather than wild-type mice
Include both in vitro and in vivo fertility assessments to comprehensively evaluate sperm function
Consider generating and analyzing RNF133/RNF148 double knockout (DKO) mice to assess potential functional redundancy
Include temporal expression analysis across multiple developmental timepoints (P5-P60) to establish precise expression patterns
This approach has successfully demonstrated that while RNF133 KO males showed only 10.0 ± 10% pregnancy success compared to 100% in HET controls, combined deletion of paralogous RNF148 did not significantly worsen this phenotype, indicating limited functional compensation .
For effective recombinant RNF133 protein production, researchers should consider:
Expression in mammalian cell systems (particularly HEK293 cells) rather than bacterial systems to ensure proper protein folding and post-translational modifications
Inclusion of appropriate epitope tags (His, Avi, or Fc) to facilitate purification without disrupting protein function
Verification of proper subcellular localization to the ER membrane through immunofluorescence
Careful buffer optimization during purification to maintain the integrity of the transmembrane domain
When expressing recombinant RNF133, it's important to verify that the protein localizes correctly to the ER, as mislocalization may lead to artifacts in functional studies .
RNF133 has been identified as an interaction partner for UBE2J1, an ER-localized E2 ubiquitin-conjugating enzyme also essential for spermiogenesis. Both proteins contain transmembrane domains and localize to the ER, suggesting they function as a complex in ERAD during spermatogenesis. The RNF133-UBE2J1 interaction represents a crucial ubiquitin-regulatory system for protein quality control during sperm development .
To investigate this interaction further, researchers should consider:
Co-immunoprecipitation studies to confirm physical interaction
In vitro ubiquitination assays to demonstrate functional cooperation
Identification of shared substrates through comparative proteomic analysis of single and double knockout models
Despite sharing 58.9% and 54.9% sequence identity in mouse and human respectively, RNF133 and RNF148 display limited functional redundancy. While RNF133 knockout males exhibit severe subfertility, RNF148 knockout males retain normal fertility. Both proteins contain similar domain structures (transmembrane domain and RING finger domain) and are chromosomally linked, suggesting they arose from gene duplication .
This presents an interesting evolutionary question regarding their functional divergence. Analysis of their expression patterns shows they are both expressed around postnatal day 25, corresponding to the round-to-elongating spermatid transition phase, yet they appear to have distinct functions in spermatogenesis .
Ultrastructural analysis of RNF133 knockout sperm reveals retention of cytoplasmic droplets, suggesting defects in the final remodeling steps of spermiogenesis. These structural abnormalities likely contribute to the observed reduced motility and fertilization capacity .
At the molecular level, this phenotype is consistent with impaired ERAD function, similar to that observed in UBE2J1 knockout mice. The retention of cytoplasmic components suggests a failure to properly eliminate unnecessary proteins and organelles during sperm maturation, a process that typically relies on ubiquitin-mediated degradation .
When analyzing fertility data from RNF133 knockout mice, researchers should consider:
| Parameter | RNF133 HET (Control) | RNF133 KO | Interpretation |
|---|---|---|---|
| Pregnancy success rate | 100 ± 0% | 10.0 ± 10% | Severe subfertility |
| Pups per plug | 8.4 ± 0.24 | 0.15 ± 0.15 | Dramatically reduced fecundity |
| In vitro fertilization rate | 83.9 ± 8.2% | 6.8 ± 3.0% | Severely impaired gamete interaction |
| 2-cell embryo formation | 73.1 ± 10.0% | 1.4 ± 0.7% | Defects in early embryo development |
This dramatic reduction in fertility parameters indicates that RNF133 is crucial for sperm function, with its absence creating defects that cannot be compensated by other ubiquitin ligases, including its paralog RNF148 .
Several research questions remain unresolved regarding RNF133 function:
Despite structural similarities between RNF133 and RNF148, they exhibit remarkably different physiological requirements, with only RNF133 being essential for fertility
The specific substrates of RNF133 during spermatogenesis remain unidentified, making it difficult to establish direct molecular mechanisms
The retention of cytoplasmic droplets in knockout sperm suggests defects in cytoplasmic elimination, yet the specific ubiquitinated proteins involved in this process are unknown
These contradictions highlight the need for further research into the specific molecular mechanisms and substrates of RNF133 .
To identify physiological substrates of RNF133, researchers should consider a multi-faceted approach:
Comparative proteomic analysis of testicular tissue from wild-type and RNF133 knockout mice at specific developmental stages
Proximity-based labeling techniques (BioID or TurboID) using RNF133 as bait to identify proteins in close proximity
Ubiquitin remnant profiling to identify ubiquitination sites that are reduced in RNF133 knockout tissues
In vitro ubiquitination assays with recombinant RNF133, UBE2J1, and candidate substrates
These approaches would help identify proteins that accumulate in the absence of RNF133-mediated ubiquitination and degradation, providing insights into its role in sperm development .
Given the testis-specific expression of RNF133 and its essential role in male fertility, it represents a potential non-hormonal male contraceptive target. Research approaches should include:
Development of small-molecule inhibitors of the RNF133 RING domain activity
Exploration of PROTACs (Proteolysis Targeting Chimeras) technology to degrade RNF133
Assessment of reversibility by evaluating sperm function after drug withdrawal
Comparative analysis with other testis-specific E3 ligases (RNF148, RNF151, ZSWIM2) to identify the most promising targets
This approach aligns with the emerging interest in developing non-hormonal male contraceptives that specifically target testis-expressed proteins essential for fertility .
RNF133 is conserved across mammalian species, including mice, humans, and domestic cats. To study its evolutionary significance:
Perform comparative sequence analysis across species to identify conserved domains and motifs
Analyze expression patterns in reproductive tissues of different mammals
Determine if the RNF133-UBE2J1 interaction is conserved across species
Investigate whether the male fertility requirement is maintained in other animal models
Understanding the evolutionary conservation of RNF133 would provide insights into its fundamental role in mammalian reproduction and help identify functionally critical regions of the protein .